Biotechnologie

The biotech industry is leading healthcare innovation with transformative therapies for complex diseases. Xenon Pharmaceuticals is close to approval for a new epilepsy treatment in Phase 3 trials. Karuna Therapeutics'…

UNITY Biotechnology is set to present promising results from their Phase 2b ASPIRE study on March 24, 2025, with potential breakthroughs in treating Diabetic Macular Edema (DME). The innovative compound…